Il-6 inhibits the tolerogenic function of CD8α+ dendritic cells expressing indoleamine 2,3-dioxygenase

Journal of Immunology

Volumn 167, Issue 2, 2001, Pages 708-714

  Grohmann, U ^a   Fallarino, F ^a   Bianchi, R ^a   Belladonna, M L ^a   Vacca, C ^a   Orabona, C ^a   Uyttenhove, C ^a   Fioretti, M C ^a   Puccetti, P ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 12; INTERLEUKIN 6; NEUTRALIZING ANTIBODY; PROTEIN NRP A7; PROTEIN P815AB; RECOMBINANT INTERLEUKIN 6; SYNTHETIC PEPTIDE; TRYPTOPHAN; TUMOR PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL METABOLISM; CELL SUBPOPULATION; CONTROLLED STUDY; CYTOFLUOROMETRY; DENDRITIC CELL; DIABETOGENESIS; IMMUNOLOGICAL TOLERANCE; MALE; MASTOCYTOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; T LYMPHOCYTE ACTIVATION;

EID: 0035879111     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.2.708     Document Type: Article

References (54)

1. IL-12 is both required and sufficient for initiating T cell reactivity to a class I-restricted tumor peptide (P815AB) following transfer of P815AB-pulsed dendritic cells
2. A tumor-associated and self antigen peptide presented by dendritic cells may induce T cell anergy in vivo, but IL-12 can prevent or revert the anergic state
3. + lymphocytes in the initiation of class I-restricted reactivity to a tumor/self peptide
4. + T cell response against one peptide/MHC complex in autoimmune diabetes
5. Progression of autoimmune diabetes driven by avidity maturation of a T-cell population
6. IL-12 acts directly on DC to promote nuclear localization of NF-κB and primes DC for IL-12 production
7. - dendritic cells to enhance presentation of a tumor peptide in vivo
8. + subset
9. Autocrine IL-12 is involved in dendritic cell modulation via CD40 ligation
10. CD40 ligation ablates the tolerogenic potential of lymphoid dendritic cells
11. Dendritic cells and the control of immunity
12. The evolution of self-tolerance: A new cell arises to meet the challenge of self-reactivity
13. The control of T cell responses by dendritic cell subsets
14. How can dendritic cells cause autoimmune disease?
15. Interleukin 6 plays a key role in the development of antigen-induced arthritis
16. Interleukin 6 is required for the development of collagen-induced arthritis
17. IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis
18. Interleukin-6 functions in autoimmune encephalomyelitis: A study in gene-targeted mice
19. IL-6-deficient mice are resistant to the induction of experimental autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein
20. IL-6-deficient mice am resistant to experimental autoimmune encephalomyelitis: Roles of IL-6 in the activation and differentiation of autoreactive T cells
21. Interleukin 6 dependence of anti-DNA antibody production: Evidence for two pathways of autoantibody formation in pristane-primed induced lupus
22. Regulation of autoimmunity by proinflammatory cytokines
23. Mice with a disrupted IFN-γ gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE)
24. Interferon-γ confers resistance to experimental allergic encephalomyelitis
25. Transfer of dendritic cells (DC) ex vivo stimulated with interferon-γ (IFN-γ) down-modulates autoimmune diabetes in non-obese diabetic (NOD) mice
26. Enhancement by IL-12 of the cytolytic T lymphocyte (CTL) response of mice immunized with tumor-specific peptides in an adjuvant containing Q21 and MPL
27. Functional and biochemical characterization of mouse p40/IL-9 receptors
28. B cell growth and differentiation activity of interleukin-HP1 and related murine plasmacytoma growth factors: Synergy with interleukin 1
29. A monoclonal antibody specific for the murine IL-6-receptor inhibits the growth of a mouse plasmacytoma in vivo
30. CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen
31. IL-9 protects mice from Gram-negative bacterial shock: Suppression of TNFα, IL-12, and IFN-γ, and induction of IL-10
32. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cells stimulatory capacity: T-T help via APC activation
33. CD40-CD40 ligand interactions in vivo regulate migration of antigen-bearing dendritic cells from the skin to draining lymph nodes
34. Functions of CD40 on B cells, dendritic cells and other cells
35. Differentiation of myeloid dendritic cells into CD8α-positive dendritic cells in vivo
36. Development of CD8α-positive dendritic cells from a common myeloid progenitor
37. Dendritic cells: Multi-lineal and multi-functional
38. IL-6 switches the differentiation of monocytes from dendritic cells to macrophages
39. In vivo priming of T cells against cryptic determinants by dendritic cells exposed to interleukin 6 and native antigen
40. - subclasses of dendritic cells direct the development of distinct T helper cells in vivo
41. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo
42. Cytokines that regulate autoimmune responses
43. Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation
44. - or helper peptides in priming for skin test reactivity to a P815AB-related peptide
45. + T cell-dependent tumor eradication in vivo
46. Interferon γ eliminates responding CD4 T cells during mycobacterial infection by inducing apoptosis of activated CD4 T cells
47. Inhibition of T cell proliferation by macrophage tryptophan catabolism
48. Tryptophan catabolism and T cell tolerance: Immunosuppression by starvation?
49. Thymic dendritic cells and T cells develop simultaneously within the thymus from a common precursor population
50. Thymic dendritic cells precursors: Relationship to the T lymphocyte lineage and phenotype of the dendritic cell progeny
51. The linkage between T-cell and dendritic cell development in the mouse thymus
52. Will the making of plasmacytoid dendritic cells in vitro help unravel their mysteries?
53. Fully competent dendritic cells as inducers of T cell anergy in autoimmunity
54. Antigen-specific inhibition of effect or T cell function in humans after injection of immature dendritic cells